Log In
BCIQ
Print this Print this
 

oxycodone (PF614)

  Manage Alerts
Collapse Summary General Information
Company Ensysce Biosciences Inc.
DescriptionTrypsin-activated, extended-release oxycodone prodrug that uses Bio-MD abuse-resistant technology
Molecular Target Mu opioid receptor (MOR) (OPRM1)
Mechanism of ActionMu opioid receptor agonist
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentPhase I
Standard IndicationPain
Indication Details Treat moderate to severe pain; Treat pain
Regulatory Designation
Partner

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
Total Number of DealsTotal Deal ValueTotal Upfront CashTotal Milestone Payments

1

0

0

0


 Deals Details
DateCompanies InvolvedDeal HeadlineTotal Deal ValueTotal Upfront CashTotal Milestone

12/31/2015

Undisclosed

Undisclosed

Undisclosed

Get a free BioCentury trial today